Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, June 30, 2023
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
Jason Butler Reiterated (AQST) at Buy and Held Target at $8 on, Jun 30th, 2023
Jason Butler of JMP Securities, Reiterated "Aquestive Therapeutics, Inc." (AQST) at Buy and Held Target at $8 on, Jun 30th, 2023.
Jason has made no other calls on AQST in the last 4 months.
There are 2 other peers that have a rating on AQST. Out of the 2 peers that are also analyzing AQST, 0 agree with Jason's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Jason
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $5 on, Wednesday, June 21st, 2023
- Andreas Argyrides of "Wedbush" Upgraded from Hold to Buy and Increased Target to $4 on, Thursday, March 9th, 2023
